Is Dechra Pharmaceuticals stock a buy?

Yes, Dechra Pharmaceuticals pays dividends. Last time was Thursday 13th of April 2023 where the investors holding the stock on Thursday 9th of March 2023 were paid GBP12.5 per share. Over the last 45 times between 2001 and 2023, Dechra Pharmaceuticals has paid GBP1352.34861 with an average of GBP30.05 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Dechra Pharmaceuticals 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was GBP2 572.00, you would have made a profit of GBP1 294.00 per share or 50.31%

Yes, the average daily trading liquidity for Dechra Pharmaceuticals is GBP1.36 million. You should therefore be able to get in and out of your positions relatively fast.

Dechra Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Dechra Pharmaceuticals to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.